Guillain-Barré syndrome is an acute inflammatory demyelinating polyneuropathy characterized by progressive muscle weakness and loss of reflexes. It has an annual incidence of 0.6 to 2.4 cases per 100,000 people and is the most common cause of acute flaccid paralysis. The syndrome is believed to be caused by an autoimmune response affecting the peripheral nervous system, usually following a bacterial or viral infection. Symptoms include numbness and tingling in the limbs followed by ascending paralysis. Treatment involves supportive care such as ventilation and intravenous immunoglobulin or plasmapheresis to reduce morbidity.